Related references
Note: Only part of the references are listed.Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease
A. Godier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Lipoprotein(a): more interesting than ever after 50 years
Joseph B. Dube et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
So Many Plasminogen Receptors: Why?
Edward F. Plow et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease A Rationale for Increased Efforts to Understand its Pathophysiology and Develop Targeted Therapies
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Lipoprotein(a) and ischemic heart disease-A causal association? A review
Pia R. Kamstrup
ATHEROSCLEROSIS (2010)
Analysis of the mechanism of lipoprotein(a) assembly
Marlys L. Koschinsky et al.
CLINICAL GENETICS (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Plasminogen and Its Receptors as Regulators of Cardiovascular Inflammatory Responses
Riku Das et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2010)
A Novel Function of Thrombin-activatable Fibrinolysis Inhibitor during Rat Liver Regeneration and in Growth-promoted Hepatocytes in Primary Culture
Nobuaki Okumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lipoprotein(a) levels and risk of future coronary heart disease
Anna Bennet et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation
N. T. Feric et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Lipoprotein (a) and venous thromboembolism in adults: A meta-analysis
Francesco Sofi et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Different apoprotein(a) isoform proportions in serum and carotid plaque
Goretta Baldo et al.
ATHEROSCLEROSIS (2007)
Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease
Benjamin Dieplinger et al.
CLINICAL CHEMISTRY (2007)
Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells
Lindsey A. Miles et al.
JOURNAL OF NEUROSCIENCE (2006)
Lipoprotein(a): A unique risk factor for cardiovascular disease
Erdembileg Anuurad et al.
CLINICS IN LABORATORY MEDICINE (2006)
Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10
AR Belczewski et al.
BIOCHEMISTRY (2005)
Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity
ML Koschinsky et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly
L Becker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A central role for plasminogen in the inflammatory response to biomaterials
SJ Busuttil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Identification of sequences in apolipoprotein(a) that maintain its closed conformation: A novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation
L Becker et al.
BIOCHEMISTRY (2004)
Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-β activation and on the presence of kringle IV type 9
CH O'Neil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lp(a) lipoprotein, vascular disease, and mortality in the elderly
AA Ariyo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibition of plasminogen activation by lipoprotein(a) - Critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces
MA Hancock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression of nuclear receptors and apo E secretion during the differentiation of monocytic THP-1 cells into macrophages
A Perez et al.
CELL BIOLOGY AND TOXICOLOGY (2003)
The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase
DK Fogg et al.
BIOCHEMISTRY (2002)
Conversion of glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface
Y Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
